Values First Advisors, Inc. Aura Biosciences, Inc. Transaction History
Values First Advisors, Inc.
- $169 Million
- Q1 2024
A detailed history of Values First Advisors, Inc. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 27,291 shares of AURA stock, worth $191,309. This represents 0.13% of its overall portfolio holdings.
Number of Shares
27,291
Previous 10,929
149.71%
Holding current value
$191,309
Previous $96,000
122.92%
% of portfolio
0.13%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
39.9MCall Options Held
400Put Options Held
1.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$48.5 Million0.5% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$40.7 Million0.73% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.47MShares$31.3 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.68MShares$25.8 Million0.01% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$21.3 Million6.26% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $205M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...